159 related articles for article (PubMed ID: 17675483)
1. Multiple constraints at the level of TCRalpha rearrangement impact Valpha14i NKT cell development.
Hager E; Hawwari A; Matsuda JL; Krangel MS; Gapin L
J Immunol; 2007 Aug; 179(4):2228-34. PubMed ID: 17675483
[TBL] [Abstract][Full Text] [Related]
2. Targeted expression of human CD1d in transgenic mice reveals independent roles for thymocytes and thymic APCs in positive and negative selection of Valpha14i NKT cells.
Schümann J; Pittoni P; Tonti E; Macdonald HR; Dellabona P; Casorati G
J Immunol; 2005 Dec; 175(11):7303-10. PubMed ID: 16301636
[TBL] [Abstract][Full Text] [Related]
3. Genetic evidence supporting selection of the Valpha14i NKT cell lineage from double-positive thymocyte precursors.
Egawa T; Eberl G; Taniuchi I; Benlagha K; Geissmann F; Hennighausen L; Bendelac A; Littman DR
Immunity; 2005 Jun; 22(6):705-16. PubMed ID: 15963785
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms imposing the Vbeta bias of Valpha14 natural killer T cells and consequences for microbial glycolipid recognition.
Wei DG; Curran SA; Savage PB; Teyton L; Bendelac A
J Exp Med; 2006 May; 203(5):1197-207. PubMed ID: 16651387
[TBL] [Abstract][Full Text] [Related]
5. A novel mouse model for invariant NKT cell study.
Wakao H; Kawamoto H; Sakata S; Inoue K; Ogura A; Wakao R; Oda A; Fujita H
J Immunol; 2007 Sep; 179(6):3888-95. PubMed ID: 17785826
[TBL] [Abstract][Full Text] [Related]
6. CD1d-specific NK1.1+ T cells with a transgenic variant TCR.
Sköld M; Faizunnessa NN; Wang CR; Cardell S
J Immunol; 2000 Jul; 165(1):168-74. PubMed ID: 10861049
[TBL] [Abstract][Full Text] [Related]
7. Immediate antigen-specific effector functions by TCR-transgenic CD8+ NKT cells.
Wingender G; Berg M; Jüngerkes F; Diehl L; Sullivan BA; Kronenberg M; Limmer A; Knolle PA
Eur J Immunol; 2006 Mar; 36(3):570-82. PubMed ID: 16506291
[TBL] [Abstract][Full Text] [Related]
8. Cutting edge: influence of the TCR Vbeta domain on the selection of semi-invariant NKT cells by endogenous ligands.
Schümann J; Mycko MP; Dellabona P; Casorati G; MacDonald HR
J Immunol; 2006 Feb; 176(4):2064-8. PubMed ID: 16455960
[TBL] [Abstract][Full Text] [Related]
9. DOCK2 is required in T cell precursors for development of Valpha14 NK T cells.
Kunisaki Y; Tanaka Y; Sanui T; Inayoshi A; Noda M; Nakayama T; Harada M; Taniguchi M; Sasazuki T; Fukui Y
J Immunol; 2006 Apr; 176(8):4640-5. PubMed ID: 16585555
[TBL] [Abstract][Full Text] [Related]
10. Human invariant V alpha 24-J alpha Q TCR supports the development of CD1d-dependent NK1.1+ and NK1.1- T cells in transgenic mice.
Capone M; Cantarella D; Schümann J; Naidenko OV; Garavaglia C; Beermann F; Kronenberg M; Dellabona P; MacDonald HR; Casorati G
J Immunol; 2003 Mar; 170(5):2390-8. PubMed ID: 12594262
[TBL] [Abstract][Full Text] [Related]
11. Development of CD1d-restricted NKT cells in the mouse thymus.
Dao T; Guo D; Ploss A; Stolzer A; Saylor C; Boursalian TE; Im JS; Sant'Angelo DB
Eur J Immunol; 2004 Dec; 34(12):3542-52. PubMed ID: 15549774
[TBL] [Abstract][Full Text] [Related]
12. A subset of NKT cells that lacks the NK1.1 marker, expresses CD1d molecules, and autopresents the alpha-galactosylceramide antigen.
Hameg A; Apostolou I; Leite-De-Moraes M; Gombert JM; Garcia C; Koezuka Y; Bach JF; Herbelin A
J Immunol; 2000 Nov; 165(9):4917-26. PubMed ID: 11046017
[TBL] [Abstract][Full Text] [Related]
13. The complementarity determining region 2 of BV8S2 (V beta 8.2) contributes to antigen recognition by rat invariant NKT cell TCR.
Pyz E; Naidenko O; Miyake S; Yamamura T; Berberich I; Cardell S; Kronenberg M; Herrmann T
J Immunol; 2006 Jun; 176(12):7447-55. PubMed ID: 16751390
[TBL] [Abstract][Full Text] [Related]
14. Does the developmental status of Valpha14i NKT cells play a role in disease?
Matsuda JL; Gapin L
Int Rev Immunol; 2007; 26(1-2):5-29. PubMed ID: 17454262
[TBL] [Abstract][Full Text] [Related]
15. T cell factor-1 controls the lifetime of CD4+ CD8+ thymocytes in vivo and distal T cell receptor α-chain rearrangement required for NKT cell development.
Sharma A; Berga-Bolaños R; Sen JM
PLoS One; 2014; 9(12):e115803. PubMed ID: 25536344
[TBL] [Abstract][Full Text] [Related]
16. Role of the complementarity-determining region 3 (CDR3) of the TCR-beta chains associated with the V alpha 14 semi-invariant TCR alpha-chain in the selection of CD4+ NK T Cells.
Ronet C; Mempel M; Thieblemont N; Lehuen A; Kourilsky P; Gachelin G
J Immunol; 2001 Feb; 166(3):1755-62. PubMed ID: 11160221
[TBL] [Abstract][Full Text] [Related]
17. CD1d-lipid-antigen recognition by the semi-invariant NKT T-cell receptor.
Borg NA; Wun KS; Kjer-Nielsen L; Wilce MC; Pellicci DG; Koh R; Besra GS; Bharadwaj M; Godfrey DI; McCluskey J; Rossjohn J
Nature; 2007 Jul; 448(7149):44-9. PubMed ID: 17581592
[TBL] [Abstract][Full Text] [Related]
18. RORgammaT, a thymus-specific isoform of the orphan nuclear receptor RORgamma / TOR, is up-regulated by signaling through the pre-T cell receptor and binds to the TEA promoter.
Villey I; de Chasseval R; de Villartay JP
Eur J Immunol; 1999 Dec; 29(12):4072-80. PubMed ID: 10602018
[TBL] [Abstract][Full Text] [Related]
19. A critical role for the T cell receptor alpha-chain connecting peptide domain in positive selection of CD1-independent NKT cells.
Capone M; Troesch M; Eberl G; Hausmann B; Palmer E; MacDonald HR
Eur J Immunol; 2001 Jun; 31(6):1867-75. PubMed ID: 11433383
[TBL] [Abstract][Full Text] [Related]
20. Invariant V alpha 14+ NKT cells participate in the early response to enteric Listeria monocytogenes infection.
Ranson T; Bregenholt S; Lehuen A; Gaillot O; Leite-de-Moraes MC; Herbelin A; Berche P; Di Santo JP
J Immunol; 2005 Jul; 175(2):1137-44. PubMed ID: 16002715
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
